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576Objectives: Patients with congenitally corrected transposition of the great arteries can present with tricuspid
regurgitation (TR) and Ebsteinoid dysplasia of the tricuspid valve. To determine the fate of the tricuspid valve
after anatomic repair and the effectiveness of tricuspid valvuloplasty, we reviewed our experience with anatomic
repair of congenitally corrected transposition of the great arteries.
Methods: From 1992 to 2012, 106 patients with congenitally corrected transposition of the great arteries
underwent anatomic repair. Of the 106 patients, 24 (22.6%) had moderate or greater TR before anatomic repair,
14 of whom had Ebsteinoid dysplasia. Nine patients (8.5%) had Ebsteinoid dysplasia without significant
TR, and 73 patients (68.9%) had neither TR nor dysplasia.
Results: Of the 106 patients, 6 (5.6%) with TR underwent tricuspid valvuloplasty at anatomic repair, 5 with
(21%) and 1 without (11%) Ebsteinoid dysplasia (P<.001). During a median follow-up period of 32 months,
of the 24 patients with TR before anatomic repair, all 6 who had undergone tricuspid valvuloplasty had mild TR
or less at the latest follow-up visit; 15 of the 18 (83%) without valvuloplasty had mild TR or less (P ¼ .4) and
3 (16.7%) had moderate or greater TR. Of the 14 patients with Ebsteinoid dysplasia and TR, 5 underwent
valvuloplasty and had no significant TR during follow-up; 2 of the 9 (22.2%) without valvuloplasty had
moderate or greater TR (P ¼ .51). Valvuloplasty was associated with an absolute risk of TR reduction
of 16.7%, which was further reduced by 22.2% in patients with associated Ebsteinoid dysplasia.
Conclusions: Tricuspid valve function significantly improved after anatomic repair, independent of direct
surgical intervention. For significant TR associated with Ebsteinoid dysplasia, valvuloplasty should be
considered. (J Thorac Cardiovasc Surg 2014;147:576-80)Congenitally corrected transposition of the great arteries
(ccTGA), although rare and representing <1% of all
congenital heart defects,1 is often associated with tricuspid
regurgitation (TR), with or without dysplasia of the
tricuspid valve that mimics the tricuspid valve dysplasia
seen in Ebstein’s anomaly.2 TR is an integral part of the
natural history of this anatomy owing to functional tricuspid
valve dysfunction, because it is associated with right
ventricular (RV) dysfunction. It will improve when the
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The Journal of Thoracic and Cardiovascular Surginversed and the ventricular septum shifts, such as after
pulmonary artery banding for LV preparation3,4 or
anatomic repair,5 placing the tricuspid valve as the
low-pressure, subpulmonary atrioventricular valve.
Ebsteinoid dysplasia of the tricuspid valve in ccTGA
represents a variable spectrum of disease, with failure of
delamination of the tricuspid valve leaflets from the RV
wall and subsequent tethering and apical displacement of
the leaflet hinge points, maximally at the commissure
between the posterior and septal leaflets.6We have preferred
the term ‘‘Ebsteinoid dysplasia’’ for this lesion, because
significant differences exist between it and Ebstein’s
anomaly7 with a concordant atrioventricular connection
compared with the tricuspid dysplasia seen in atrioventri-
cular discordance: The atrialized portion of the right
ventricle is not thinned, rarely the mural or septal leaflet
can be absent, and it has been associated with a ventricular
septal defect6 and aortic arch obstruction.8
Physiologic repair of ccTGA, in which the right ventricle
is left in the systemic position, and associated anomalies,
such as TR, ventricular septal defect, and pulmonary
atresia, are repaired, carries a high risk, and patients are
often referred late for surgical repair, when the systemic
RV function has started to decline.9 In this setting, repairery c February 2014
Abbreviations and Acronyms
ccTGA ¼ Congenitally corrected transposition of
the great arteries
LV ¼ left ventricular
mRV ¼ morphologic right ventricle
RV ¼ right ventricular
TR ¼ tricuspid regurgitation
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supports the systemic circulation, and valve replacement
has been advocated,10 albeit at a high operative risk.
Anatomic repair, which corrects atrioventricular and
ventriculoarterial discordance using a double-switch
procedure, places the right ventricle and tricuspid valve in
the pulmonary position. It is a promising solution that has
shown low operative mortality and good functional results
compared with physiologic repair.1,11-14
Murtuza and colleagues14 reported, among 113 patients
who had undergone anatomic repair, a prevalence of Ebstei-
noid dysplasia of the tricuspid valve of 12.3% (n¼ 14), and
6 patients (5.3%) had severe TR. Currently, little informa-
tion is available regarding the best management of signifi-
cant TR, in particular, when associated with Ebsteinoid
dysplasia at anatomic repair of ccTGA. The goal of the pre-
sent study was to review our experience in managing the
tricuspid valve in patients with significant TR at anatomic
repair and infer the best surgical option for treatment.
METHODS
Study Design
The present study was a retrospective review of all patients with ccTGA
who had undergone anatomic repair at our institution from 1992 to 2012.
The Boston Children’s Hospital institutional review board approved the
present study, and individual patient consent was waived.
The primary endpoints were moderate or greater TR and tricuspid valve
reoperation after anatomic repair. The clinical and treatment variables were
recorded to determine the predictors of the endpoints. All patients
underwent follow-up examination to death or June 2012.
Surgical Technique
The surgical techniques used in the present study population have been
previously reported in detail.15 The decision to address the tricuspid
valve at anatomic repair was determined from the preoperative
echocardiographic findings of the presence of moderate or greater TR
and a discernable structural defect, such as a tethered septal leaflet, cleft,
or splayed-open anteroseptal commissure. The surgical techniques were
tailored to the mechanism responsible for regurgitation at the discretion
of the operating surgeon. Exposing the tricuspid valve can be challenging
in patients with ccTGA and mesocardia, because the ventricular mass lies
anterior to the atrial mass. In these patients, we rotate the ventricular mass
into the left pleural space in situs solitus or the right pleural space in situs
inversus to expose the tricuspid valve.
Statistical Analysis
Statistical analyses were performed using the Statistical Package for
Social Sciences software, version 21 (SPSS, Inc, Chicago, Ill). The dataThe Journal of Thoracic and Caare presented as mean  standard deviation or median and range,
as appropriate. Continuous variables were analyzed using the related
samples Wilcoxon signed rank test or the Kruskal-Wallis 1-way analysis
of variance test, and categorical variables using the chi-square test or
Fisher’s exact test. All statistical tests were 2-tailed, and P< .05 was
considered significant.
RESULTS
Study Population
The study population has previously been described in
detail.16 A total of 106 consecutive patients underwent
anatomic repair for ccTGA during the study period. The
median age at surgery was 1.2 years (range, 2 months to
43 years). The segmental anatomy was SLL (situs solitus,
L-loop ventricles, L-transposed great arteries) in 93 patients
(87.7%) and IDD (situs inversus, D-loop ventricules,
D-transposed great arteries) in 13 patients (12.3%).
Levocardia was present in 63 patients (59.4%), dextrocar-
dia in 24 (22.6%), and mesocardia in 9 (8.5%). Atrial
switch was accomplished using a modified Senning
procedure in 35 patients (33%) and a Mustard procedure
in 71 (67%). Also, 42 patients (39.6%) had undergone
a Rastelli procedure for LV outflow reconstruction
and 62 (58.5%) arterial switch for restoration of the
ventriculoarterial concordance. Two patients (1.9%) had
undergone a Nikaidoh procedure late in our experience.
A detailed breakdown of the patient subgoups and
outcomes are summarized in Figure 1. Of the 106 patients,
24 (22.6%) had moderate or severe TR before anatomic
repair, 15 of whom had Ebsteinoid dysplasia of the
tricuspid valve. Another 9 patients (8.5%) had Ebsteinoid
dysplasia without significant TR, and 73 patients (68.9%)
had neither TR nor dysplasia and were used as controls.
Of the patients with TR, 9 (37.5%) had previously
undergone pulmonary artery banding, and 15 of the
controls had also (20.5%; P ¼ .08). The patient baseline
characteristics are summarized in Table 1. More patients
with significant TR and/or Ebsteinoid dysplasia had
undergone arterial switch (29 of 35) than a Rastelli
procedure (6 of 35; P ¼ .007).
Tricuspid Valvuloplasty at Anatomic Repair
Six patients (5.6%, all in the TR group) had undergone
tricuspid valvuloplasty at anatomic repair, 5 with
Ebsteinoid dysplasia (20.8%) and 1 without Ebsteinoid
dysplasia (11.1%; P < .001). The repair techniques
consisted predominantly of anteroseptal commissure
closure and suture annuloplasty (Table 2). The predominant
lesion responsible for regurgitation found on tricuspid valve
inspection was a cleft on the septal leaflet or a splayed-open
anteroseptal commissure, with thickened and rolled edges
from TR. This was addressed by cleft closure, closure of
the regurgitant anteroseptal commissure and/or partial
suture annuloplasty, annulus plication, or commissuro-
plasty. All 6 patients who had undergone valvuloplastyrdiovascular Surgery c Volume 147, Number 2 577
FIGURE 1. Flowchart of patient subgroups and outcomes. ccTGA, Congenitally corrected transposition of the great arteries; TR, tricuspid valve
regurgitation; TV, tricuspid valve; TVP, tricuspid valvuloplasty.
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a Rastelli or Nikaidoh procedure.
Outcomes After Anatomic Repair
Of the 106 patients, 6 died early (5.7%) and 3 died late
during a median follow-up of 32 months (range, 7 days to
7.2 years) after anatomic repair. Stratified by group, 1 early
death occurred in the TR group (4.2%), none in the
Ebsteinoid dysplasia group, and 5 in the control group
(6.8%, P>.99). Overall, 2 patients in the TR group diedTABLE 1. Patient baseline and operative characteristics
Variable TR
Ebsteinoid
dysplasia Controls
P
value
Patients (n) 24 9 73
Age (y) 1.1 (0.2-39.6) 1.6 (0.4-9.6) 1.2 (0.2-43) .98
Weight (kg) 9.4 (4-67) 8.6 (4-40) 9.7 (3-66) .98
Segmental anatomy
SLL 23 (95.8) 9 (100) 61 (83.6) .19
IDD 1 (4.2) 0 (0) 12 (16.4) .19
Associated anomalies
VSD 19 (79.2) 6 (66.7) 68 (93.2) .02
Pulmonary stenosis 9 (37.5) 1 (11.1) 32 (43.8) .15
Pulmonary atresia 2 (8.3) 2 (22.2) 27 (37) .02
Ebsteinoid dysplasia 14 (58.3) 9 (100) 0 (0) <.001
Moderate or more TR 24 (100) 0 (0) 0 (0) <.001
Previous PA band 9 (37.5) 6 (66.7) 15 (20.5) .009
Atrial switch .60
Modified Senning 10 (41.7) 3 (33.3) 22 (30.1)
Mustard 14 (58.3) 6 (66.7) 51 (69.9)
Arterial switch .007
Arterial switch 21 (87.5) 6 (66.7) 35 (47.9)
Rastelli 3 (12.5) 3 (33.3) 36 (49.3)
Nikaidoh 2 (2.7) 0 (0) 0 (0)
Data presented as median (range) or n (%). TR, Tricuspid regurgitation; SLL, situs
solitus, L-loop ventricles, L-transposed great arteries; IDD, situs inversus, D-loop
ventricules, D-transposed great arteries; VSD, ventricular septal defect; PA, pulmo-
nary artery.
578 The Journal of Thoracic and Cardiovascular Surg(8.3%), none in the Ebsteinoid dysplasia group, and 7 in
the control group (9.6%, P>.99).
Of the 24 patients with significant TR before
anatomic repair, all 6 patients who had undergone tricuspid
valvuloplasty had mild or less TR at the latest follow-
up visit. Of the 18 patients who did not have the tricuspid
valve addressed, 15 (83%) had mild or less TR and
3 (17%), with preoperative significant TR, had moderate or
severe TR (P ¼ .4), all with an Ebsteinoid tricuspid valve.
The outcomes of patients with Ebsteinoid dysplasia are
summarized in Figure 2. Of the 23 patients with Ebsteinoid
dysplasia of the tricuspid valve (with or without significant
TR before anatomic repair), all 5 patients who had
undergone valvuloplasty had mild or less TR at the
latest follow-up examination, and 3 of the 18 without
valvuloplasty (16.7%) had moderate or more TR
(P ¼ .46). Of the 14 patients with Ebsteinoid dysplasia
and TR, 5 had undergone valvuloplasty and had no
significant TR during the follow-up period, and 2 of 9
without valvuloplasty (22.2%) had moderate or more TR
(P ¼ .51). In summary, although these differences between
patients with and without valvuloplasty were not
statistically significant, in patients with TR or Ebsteinoid
dysplasia, valvuloplasty resulted in an absolute risk
reduction of TR of 16.7%. This absolute risk reduction of
TR by valvuloplasty was increased further to 22.2% inTABLE 2. Tricuspid valvuloplasty techniques at anatomic repair
Technique Patients (n)
Anteroseptal commissure closure 3
Annulus plication 1
Suture annuloplasty 1
Commissuroplasty 1
Cleft closure 1
Supravalvar ring resection 1
Two patients had>1 tricuspid valvuloplasty technique used.
ery c February 2014
FIGURE 2. Flowchart of patients with Ebsteinoid tricuspid valve. TR, Tricuspid valve regurgitation; TVP, tricuspid valvuloplasty.
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before anatomic repair.
DISCUSSION
Physiologic repair of ccTGA that addresses the
associated lesions, such as ventricular septal defects, TR,
or pulmonary artery stenosis or atresia, leaves the
morphologic right ventricle (mRV) to support the systemic
circulation. This has resulted in documented deteriorating
mRV function, TR, and survival at 1 year of 84%, with a
decline to 60% at 15 years.17,18 Anatomic repair, or the
so-called double switch, restores the morphologic left
ventricle to the systemic circulation. Clinical series have
suggested that anatomic repair is associated with low
operative mortality and superior survival and New York
Heart Association functional class.1,11-14
There is considerable debate, however, regarding the
optimal management of Ebsteinoid dysplasia of the
tricuspid valve and/or TR at anatomic repair. Restoring
the mRV to the low-pressure pulmonary circulation has
been shown to markedly reduce TR just by virtue of me-
chanical unloading of the mRVand septal shift with restora-
tion of the morphologic left ventricle to the systemic
circulation.19,20 In our experience, the TR improved
significantly after anatomic repair, even without tricuspidThe Journal of Thoracic and Cavalvuloplasty. Only 3 of 18 patients with significant TR
before anatomic repair who did not undergo valvuloplasty
and 2 of 9 patients with significant TR and Ebsteinoid
dysplasia who did not undergo valvuloplasty had
significant TR during the follow-up period. Furthermore,
this decision will be complicated further because a propor-
tion of patients with Ebstenoid dysplasia of the tricuspid
valve (9 patients in our series, representing 8.5% of our
ccTGA population and 37.5% of our patients with Ebstei-
noid dysplasia) will have mild to no TR before anatomic
repair. As the results of anatomic repair improve and enthu-
siasm for this approach to ccTGA increases, prompting
earlier referral and surgical management to avoid mRV
dysfunction, the landscape of tricuspid valve function
before anatomic repair could also improve, and the ques-
tions regarding Ebsteinoid dysplasia and mild to moderate
TR could become even more important.
However, these patients are relatively rare, and few data
exist to guide the management of the tricuspid valve in these
patients. In the largest series reported of anatomic repair for
ccTGA, Murtuza and colleagues14 reported a prevalence of
12.3% (14 of 113) for Ebsteinoid dysplasia and a
prevalence of 5.3% (6 of 113) for severe TR before
anatomic repair. Although not formally included in their
extensive report, 15 of their patients (13.2%) hadrdiovascular Surgery c Volume 147, Number 2 579
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reported strategy was to examine the tricuspid valve in all
patients at anatomic repair, and only those in whom a gap
or cleft in the valve was evident underwent repair. With
this approach, 3 patients (2.7%) required reoperation for
tricuspid valve repeat repair, and 40 patients (35.4%; data
not reported but calculated from discussion) presented
with mild to moderate TR after anatomic repair.
From these and our data, it appears that simple valve
repair techniques, far from the complexity of cone
reconstruction of the tricuspid valve,21 which can be
technically difficult with the left-sided tricuspid valve in
ccTGA and frequent dextrocardia or mesocardia, is
sufficient to ensure a reasonable result and that valvulo-
plasty has an important role in reducing the risk of TR after
anatomic repair.
The present study had several limitations. First, it was a
retrospective, noninterventional study designed to evaluate
the outcomes of an established clinical program. All
patients were treated as individuals and not according to a
treatment protocol, which would have improved our ability
to analyze the outcomes. Our analyses were limited by the
limited patient sample, although representing one of the
largest populations of anatomic repairs. Nonetheless, the
present study was the first to look into the impact of
tricuspid valve function at anatomic repair and tricuspid
valve repair techniques, along with tricuspid regurgitation
and Ebsteinoid dysplasia before anatomic repair in ccTGA.
CONCLUSIONS
TR and Ebsteinoid dysplasia of the tricuspid valve are
common in patients with ccTGA. Tricuspid valve function
improved significantly after anatomic repair in all groups.
Simple repair techniques were sufficient to avoid significant
TR at mid-term follow-up and tended to afford a reduction
in the absolute risk of TR of 16% to 22% in patients with
TR and/or Ebsteinoid dysplasia.
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